PTK2 and acute myeloid leukemia: The basis of their poor prognosis may relay in the aberrant FAK expression observed in primitive AML or leukemic stem cells (LSCs; CD45loCD34hiCD38−/loCD123+), which confers more migration capacity, while promoting their survival and enhancing their resistance to drugs, through FAK-mediated interaction with stroma [19,20,21,22].